Founded in 2004, PFM Health Sciences is a leading healthcare investment advisor currently managing approximately $2 billion in public and private investments. The firm led by Founding Partner and CIO, Brian Grossman, is focused on partnering with innovative biopharma, medical technology, life science and healthcare service companies.
We are in-the-midst of a powerful, secular healthcare innovation cycle that will continue to produce transformative, open-ended investment opportunities.
The sector is well suited to a specialist, bottom-up, fundamental approach as investors can benefit from the intersection of secular growth, domain expertise and demographic trends.
There is value in partnering with companies that will have a measurable and sustainable impact on health outcomes, while also being responsible stewards of institutional capital.
Our approach to risk management and portfolio construction is designed to dampen volatility while providing an attractive return/risk profile.
There are key advantages in having the flexibility to invest across the capital structure in both public and private companies.